North America Diabetes Care Devices Market

The North America diabetes care devices market is expected to grow from US$ 11,149.93 million in 2022 to US$ 16,386.63 million by 2028; it is estimated to grow at a CAGR of 4.9% from 2022 to 2028.

Diabetes among the geriatric population is a growing public health burden. It is a major cause of morbidity and mortality in the aging population and leads to various chronic complications. Moreover, this population is growing exponentially. As per a UN report (2019), in 2019, there were 200.4 million people aged 65 and older in North America. Moreover, according to a report by the UN (2019), the regional geriatric population is expected to double over the next three decades. The geriatric population is more likely to have diabetes than the younger population, and its effect on the quality of life is particularly more in the former population. With a rise in the geriatric population, the prevalence of diabetes has increased. Therefore, there is an increase in demand for diabetes care devices, which is driving the market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America diabetes care devices market. The North America diabetes care devices market is expected to grow at a good CAGR during the forecast period. 

North America Diabetes Care Devices Market Revenue and Forecast to 2028 (US$ Million)

North America Diabetes Care Devices Market Segmentation

The North America diabetes care devices market is segmented based on type, end user, and country. Based on type, the North America diabetes care devices market is bifurcated into glucose monitoring devices and insulin delivery devices. The glucose monitoring devices segment would dominate the market in 2022. The glucose monitoring devices segment is further categorized into testing strips, glucometer, lancets, and others. Similarly, the insulin delivery devices segment is segmented into insulin pens, insulin syringes, insulin pumps, and others. In terms of end user, the North America diabetes care devices market is bifurcated into homecare and hospitals & clinics. The homecare segment would dominate the market in 2022. Based on country, the North America diabetes care devices market has been categorized into the US, Canada, and Mexico. The US would dominate the market in 2022.

B. Braun Melsungen AG; BD; Dexcom, Inc.; Eli Lilly and Company.; F. Hoffmann-La Roche Ltd.; Insulet Corporation; Medtronic; Novo Nordisk A/S; Tandem Diabetes Care Inc.; and Terumo Corporation are among the leading companies in the North America diabetes care devices market.